Delivery Order SPE2DB22D9239-SPE2DB25FDL99
- Not listed
- The Defense Logistics Agency awarded a $12.78K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240 count). The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on July 21, 2025, carries a ceiling value of $12,782.32 and is scheduled for ultimate completion by August 11, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Alecensa 150 mg capsules (240-count units) with a ceiling value of $25.6K. This delivery order, which carries no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois....
- The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, represents a direct procurement for pharmaceutical products supporting Department of Defense healthcare needs. The contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $38,346.96 on September 18, 2025, for the supply of Alecensa 150 mg capsules (240 units). The award was issued without a set-aside designation by the Medical Supply Chain division of the Defense Logistics Agency and is scheduled for ultimate completion by October 9, 2025. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $12,782.32 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The order, issued on May 22, 2025, with an ultimate completion date of June 13, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a continuation of the companies' established relationship under the larger pharmaceutical supply framework....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. for the supply of Alecensa 150 mg capsules (240 count units). The contract was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, and carries a firm fixed-price structure with no set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters operations. DMS Pharmaceutical Group Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on August 28, 2025, with an ultimate completion date of September 19, 2025, represents a direct fulfillment of pharmaceutical needs within the federal supply chain. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa (alectinib) 150 mg capsules in quantities of 240 units. This $12,782.32 firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. The contract carries no set-aside designation, and performance will occur at the contractor's Park Ridge...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL99Delivery Order
The Defense Logistics Agency awarded a $25.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The contract was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500M through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs of military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards for branded and generic prescription drugs, biologics, and specialty medications. The company leverages its status as a woman-owned small business to compete effectively in federal procurement markets and has consistently secured delivery orders across diverse pharmaceutical product categories. Alecensa, a targeted cancer therapy used in treating non-small cell lung cancer, represents the type of specialized pharmaceutical product that supports Department of Defense healthcare operations globally through DMS Pharmaceutical Group's distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 9/18/25 |